Gene Therapy of Beta Thalassemia Using a Self-inactivating Lentiviral Vector
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT03351829 |
Recruitment Status : Unknown
Verified November 2017 by Lung-Ji Chang, Shenzhen Geno-Immune Medical Institute.
Recruitment status was: Not yet recruiting
First Posted : November 24, 2017
Last Update Posted : November 30, 2017
|
Sponsor:
Shenzhen Geno-Immune Medical Institute
Information provided by (Responsible Party):
Lung-Ji Chang, Shenzhen Geno-Immune Medical Institute
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : | Unknown |
---|---|
Estimated Primary Completion Date : | January 1, 2019 |
Estimated Study Completion Date : | December 31, 2020 |